Mavixen (Glecaprevir 100 mg & Pibrentasvir 40 mg)

Mavixen (Glecaprevir 100 mg & Pibrentasvir 40 mg) is a combined medication used to treat the hepatitis C virus and all genotypes 1 through 6 without cirrhosis and with compensated cirrhosis in adults and children above 12 years of age. Combinedly, they inhibit NS3/4A and NS5A enzymes in hepatitis C that stimulate virus replicating RNA into DNA. While using this medication, common side effects like nausea, fatigue, and diarrhea are seen in patients, which are tolerable and improve with time. GMP-certified Everest Pharmaceutical is manufacturing Mavixen as a fixed-dose combination and provides global access to the patients and healthcare providers. 

Why is it used?

Primarily, it is used to treat HCV virus infection without cirrhosis and with compensated cirrhosis in genotype 1,2,3,4,5, and 6. It is also used to treat HCV genotype 1 infection in patients who have taken treatment before with either NS5A or NS3/4A protease inhibitors, but not with both.

How does it work in HCV patients?

Glecaprevir and Pibrentasvir targets NS3/4A and NS5A enzymes in viral RNA, by blocking those enzymes, these two direct-acting antivirals (DAAs) works mutually, stopping the hepatitis C virus from replicating and producing new infectious viral particles. How does this dual mechanism allow for effective treatment across all major genotypes in HCV?

Common Side Effects

Common side effects are 

• Nausea
• Headache
• Fatigue
• Abdominal pain 
• And diarrhea

Consult your doctor immediately if the following side effects are seen

• Dark-colored urine
• headache
• large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
• light-colored stools
• stomach pain, continuing
• yellow eyes or skin

Uses in Special Cases 

• Adequate studies have not been performed if children younger than 3 years of age can benefit from this medication. Safety and efficacy also have not been established.
• There is not enough data available on pregnant women to use Mavixen about the risk to the unborn baby. 
• Using this hepatitis C therapy for breastfeeding women is also not recommended due not a studies on that, and the risk is unknown for infants. If the potential risk is higher than the outcome, it is recommended not to use it. 

Who should not use this medicine?

• If someone has been infected before with the hepatitis B virus, their liver condition is not good. 
• If patients are allergic to any of the ingredients of the medication.
• If the possibility of an outcome is less than the risk, then this medicine should not be used. 
• If someone has severe liver disease, they should not use Mavixen.

What should I do if I miss a dose?

If you miss a dose, take it as soon as possible. If you remember about the missing dose when it is time to take the next dose, it is not recommended to take the missed dose. In this case, go with the next dose and consult your health care provider. They may suggest to you what to do.

How to store Mavixen (Glecaprevir 100 mg & Pibrentasvir 40 mg)

Store the medicine at room temperature, keep it away from children and direct sunlight. Use a safe method for expired medicine disposal. Keep it in the original bottle it comes with; do not keep it in any moisturized pot or one that contains heat. 

How to access Mavixen globally?

You can access Mavixen globally through Onus Pharma, a trusted online global life-saving medicine supplier. Onus Pharma ensures on-time delivery, comprehensive customer service, genuine medicine directly from the manufacturer, and 24/7 customer support. We also ensure a refund and return policy if anything happens because of us prioritizing customer satisfaction.

Manufacturer Information

Mavixen is manufactured by the well-renowned Everest Pharmaceutical, a known name in the pharmaceutical industry for its excellence in oncology medicines. Their medicines are not only popular in the region but also among other countries in Asia, the Middle East.